InsidersTradesSigma
Follow the OKYO Pharma Ltd stock price and the full directors' dealings record of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Operating in the Health Care sector, OKYO Pharma Ltd has published 23 public disclosures. Market capitalisation: €82.4m. The latest transaction was disclosed on 7 August 2026 (Acquisition). Among the most active insiders: CERRONE GABRIELE M. All data is openly available.
23
Insider Decl.
n/a
Thresholds
€931,724
13 ops.
Buy Volume
n/a
n/a
Sell Volume
62Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 7 August 2026
Declarations23 total
5,000 shares@ US$1.477COMMON STOCKSEC:0001493152-26-036585:0
Canonical exit: 19 Oct 2026 (T+90)
22,500 shares@ US$1.45COMMON STOCKSEC:0001493152-26-036579:0
Canonical exit: 19 Oct 2026 (T+90)
25,000 shares@ US$1.40COMMON STOCKSEC:0001493152-26-036582:0
Canonical exit: 18 Oct 2026 (T+90)
15,000 shares@ US$1.539COMMON STOCKSEC:0001493152-26-036584:0
Canonical exit: 20 Oct 2026 (T+90)
3,500 shares@ US$1.40COMMON STOCKSEC:0001493152-26-036583:0
Canonical exit: 19 Oct 2026 (T+90)
20,000 shares@ US$1.40COMMON STOCKSEC:0001493152-26-036580:0
Canonical exit: 19 Oct 2026 (T+90)
3,363 shares@ US$1.49COMMON STOCKSEC:0001493152-26-036581:0
Canonical exit: 25 Oct 2026 (T+90)
3,363 shares@ US$1.490.0058% mcap100.0% of flowCOMMON STOCKSEC:0001493152-26-035212:0
5,000 shares@ US$1.4770.0097% mcap21.6% of flowCOMMON STOCKSEC:0001493152-26-034405:0
22,500 shares@ US$1.450.043% mcap1.8% of flowCOMMON STOCKSEC:0001493152-26-034408:0
15,000 shares@ US$1.5390.031% mcap100.0% of flowCOMMON STOCKSEC:0001493152-26-034409:0
3,500 shares@ US$1.400.0065% mcap8.3% of flowCOMMON STOCKSEC:0001493152-26-034406:0
20,000 shares@ US$1.400.037% mcap100.0% of flowCOMMON STOCKSEC:0001493152-26-034236:0
25,000 shares@ US$1.400.047% mcap1.9% of flowCOMMON STOCKSEC:0001493152-26-034084:0
300,000 sharesCOMMON STOCKSEC:0001493152-26-028117:0
499,468 shares@ US$1.5045.5% of flowOrdinary SharesSEC:0001493152-23-038854:0
70,071 shares@ US$1.506.4% of flowOrdinary SharesSEC:0001493152-23-038854:1
16,670 shares@ US$1.50100.0% of flowOrdinary SharesSEC:0001493152-23-034486:0
Canonical exit: 14 Dec 2023 (T+90)
5,800,000 shares@ US$0.0760.50% mcap56.2% of flowOrdinary SharesSEC:0001493152-22-014552:0
Canonical exit: 17 Aug 2022 (T+90)
12,500 shares@ US$4.000.057% mcap100.0% of flowAmerican Depositary SharesSEC:0001493152-22-014438:0
Canonical exit: 17 Aug 2022 (T+90)
37,500 shares@ US$4.000.17% mcap19.1% of flowAmerican Depositary SharesSEC:0001493152-22-014437:0
Canonical exit: 17 Aug 2022 (T+90)
25,000 shares@ US$3.870.11% mcap12.4% of flowAmerican Depositary SharesSEC:0001493152-22-014299:0
Canonical exit: 15 Aug 2022 (T+90)
1,625,000 shares@ US$0.05950.11% mcap12.4% of flowOrdinary SharesSEC:0001493152-22-014284:0
Canonical exit: 15 Aug 2022 (T+90)
23 of 23 declarations
Acerca de OKYO Pharma Ltd
OKYO Pharma Ltd es una empresa biofarmacéutica centrada en el desarrollo de tratamientos para enfermedades inflamatorias y trastornos oculares. Cotiza en NASDAQ bajo el símbolo OKYO.